Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N G Gavalas

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|July 31, 2007
Autoimmunity as an aetiological factor in vitiligoN Rezaei, N G Gavalas, A P Weetman, et al.
Clinical and Experimental Obstetrics & Gynecology|September 29, 2015
Molecular aspects and clinical methods for preserving ovarian reserves in women receiving cancer treatmentN Thomakos, S P Trachana, I Koutroumpa, et al.
Structure (London, England : 1993)|June 30, 2000
A new allosteric site in glycogen phosphorylase b as a target for drug interactionsN G Oikonomakos, V T Skamnaki, K E Tsitsanou, et al.
Genes and Immunity|July 15, 2005
A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligoI Cantón, S Akhtar, N G Gavalas, et al.
British Journal of Cancer|November 22, 2012
VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2N G Gavalas, M Tsiatas, O Tsitsilonis, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of the European Academy of Dermatology and Venereology : JEADV|July 31, 2007
Autoimmunity as an aetiological factor in vitiligoN Rezaei, N G Gavalas, A P Weetman, et al.
Clinical and Experimental Obstetrics & Gynecology|September 29, 2015
Molecular aspects and clinical methods for preserving ovarian reserves in women receiving cancer treatmentN Thomakos, S P Trachana, I Koutroumpa, et al.
Structure (London, England : 1993)|June 30, 2000
A new allosteric site in glycogen phosphorylase b as a target for drug interactionsN G Oikonomakos, V T Skamnaki, K E Tsitsanou, et al.
Genes and Immunity|July 15, 2005
A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligoI Cantón, S Akhtar, N G Gavalas, et al.
British Journal of Cancer|November 22, 2012
VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2N G Gavalas, M Tsiatas, O Tsitsilonis, et al.
Pageof 1